Page last updated: 2024-08-25

methotrexate and Dermatitis, Atopic

methotrexate has been researched along with Dermatitis, Atopic in 82 studies

Research

Studies (82)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (2.44)	18.7374
1990's	2 (2.44)	18.2507
2000's	6 (7.32)	29.6817
2010's	52 (63.41)	24.3611
2020's	20 (24.39)	2.80

Authors

Authors	Studies
Ardeleanu, M; Daoud, M; de Bruin-Weller, M; Ferrucci, SM; Jayawardena, S; Patrizi, A; Pink, AE; Schuttelaar, MLA; Svensson, A; Tauber, M	1
Cook, MK; Feldman, SR; Perche, PO	1
Agner, T; Alfonso, JH; de Graaf, M; De Schepper, S; Deleuran, M; Despontin, K; Elenius, V; Ghislain, PD; Huilaja, L; Janmohamed, SR; Johansson, EK; Kvenshagen, BK; Mandelin, JM; Olset, H; Schuttelaar, MLA; Svensson, A; Thyssen, JP; van Tuyll van Serooskerken, AM; Vestergaard, C	1
Anderson, CD; Brenneche, A; Freilich, J; Johansson, EK; Stelmaszuk, MN; Trangbaek, D	1
Munawar, L; Norden, A; Oulee, A; Thyssen, J; Wu, J	1
Cheirif-Wolosky, O; Elizalde-Jiménez, IG; Romero, MTG	1
Anand, P; Mostaghimi, A; Schneeweiss, MC; Schneeweiss, S	1
Andrawis, M; Beatty, P; Blasco, MC; Doyle, C; McFeely, O; Murphy, L; O'Mahony, S; Salim, A	1
Adam, DN; Beecker, JR; Gooderham, MJ; Hong, CH; Jack, CS; Jain, V; Lansang, P; Lynde, CW; Papp, KA; Prajapati, VH; Turchin, I; Yeung, J	1
Ashoor, F; August, S; Baron, S; Beattie, P; Brown, SJ; Browne, F; Cork, MJ; Esdaile, B; Flohr, C; Gach, JE; Greenblatt, D; Hearn, R; Hilger, E; Howard, E; Irvine, AD; Jones, AP; Lovgren, ML; McPherson, T; O'Kane, D; Ravenscroft, J; Rosala-Hallas, A; Sach, TH; Shaw, L; Sinha, MD; Spowart, C; Taams, LS; Thomas, BR; Wan, M; Williamson, PR	1
Silverberg, JI; Singh, P	1
Ariëns, LFM; Bakker, DS; de Bruin-Weller, MS; de Graaf, M; de Ridder, I; Haeck, I; Kamsteeg, M; Oosting, AJ; Romeijn, GLE; Schuttelaar, MLA; Sloeserwij, A; Spekhorst, LS; Thijs, JL; van der Schaft, J	1
Arents, BWM; Bohdanowicz, M; Burton, T; Di Giorgio, S; Drucker, AM; Ellis, AG; Flohr, C; Küster, D; Mashayekhi, S; Rochwerg, B; Schmitt, J; Siegels, D; Spuls, PI; Yiu, ZZN	1
Caldarola, G; Chiricozzi, A; D'Urso, DF; De Simone, C; Gori, N; Malvaso, D; Peris, K	1
Bacardit, J; Behjati, S; Belokhvostova, D; Botting, RA; Carey, C; Coxhead, J; Dixon, D; Dubois, A; Efremova, M; Engelbert, J; Filby, A; Fletcher, J; Goh, I; Green, K; Hagai, T; Haniffa, M; Horsfall, D; Huang, N; Husain, A; Jardine, L; Jones, C; Jones, PH; Lisgo, S; Lynch, MD; Maunder, D; McDonald, D; McGrath, J; Meyer, KB; Negri, VA; Ness, T; O'Toole, EA; Ogg, GS; Olabi, B; Park, JE; Polański, K; Popescu, DM; Poyner, EFM; Rajan, N; Reynolds, G; Reynolds, NJ; Sayer, B; Stephenson, E; Teichmann, SA; Vegh, P; Vento-Tormo, R; Villani, AC; Wang, XN; Watt, FM; Webb, S	1
Aoki, V; Samorano, LP; Takaoka, R; Zaniboni, MC	1
Bennett, M; Bourke, J; Bowe, S; Kiely, L; Murphy, M; O'Connor, C	1
Bayerl, C; Herr, R; Kromer, C; Pino Lopez, J; Schaarschmidt, ML; Schmieder, A	1
Amano, W; Hayashi, M; Kakimoto, K; Katsuda, Y; Kimoto, Y; Konishi, N; Shinozaki, Y; Taniai-Riya, E; Tanimoto, A; Toyoda, K; Yamamoto, Y	1
Beck, LA; Prezzano, JC	1
Dvorakova, V; Irvine, AD; O'Regan, GM	1
Borok, J; Davis, DM; Lio, P; Spergel, J; Udkoff, J	1
Bos, JD; Brouwer, MWD; Gerbens, LAA; Leeflang, MMG; Roekevisch, E; Schram, ME; Spuls, PI	1
Brouwer, MWD; Gerbens, LAA; Hamann, SAS; Leeflang, MMG; Roekevisch, E; Spuls, PI	1
Berard, F; Nicolas, JF; Nosbaum, A; Yfanti, I	1
Lacour, JP	1
Beneton, N; Bouzillé, G; Droitcourt, C; Dupuy, A; Law Ping Man, S; Safa, G	1
Bruijnzeel-Koomen, CAFM; de Bruin-Weller, MS; Garritsen, FM; Maitland-van der Zee, AH; van den Broek, MPH; van den Heuvel, JM	1
Ke, H; Li, J; Liang, L; Luo, X	1
Berard, F; Delcasso, B; Delcroix, F; Goujon, C; Grande, S; Hacard, F; Nicolas, JF; Nosbaum, A	1
Arenas, CM; Chalela, JG; Ordóñez Rubiano, MF	1
Ashoor, F; Baron, S; Beattie, P; Browne, F; Flohr, C; Irvine, AD; Jones, AP; O'Neill, L; Rosala-Hallas, A; Sach, T; Spowart, C; Taams, L; Walker, C; Wan, M; Webb, N; Williamson, P	1
Svensson, Å; von Kobyletzki, LB	1
Beck, LA; Bieber, T; Irvine, AD; Kabashima, K; Weidinger, S	1
Fedota, O; Merenkova, I; Roschenyuk, L; Tyzhnenko, T; Vorontsov, V	1
Barzilai, A; Baum, S; Ben Amitai, D; Greenberger, S; Taieb, Y	1
Bercovitch, L; Drucker, AM	1
Goujon, C; Nicolas, JF; Nosbaum, A	1
Deleuran, M; Ring, J; Wollenberg, A	1
Megna, M; Sidikov, AA; Skrek, SV; Timoshchuk, EA; Zaslavsky, DV	1
Alexander, H; Flohr, C; Jabbar-Lopez, ZK; Manca, A; Patton, T	1
Anderson, K; Castelo-Soccio, L; Patel, D; Putterman, E; Rogers, RS; Treat, JR	1
Agnew, K; Birchall, N; Dalziel, SR; Lee, M; Purvis, D	1
de Jong, PHP; de Wijs, LEM; Hijnen, DJ; van der Waa, JD	1
Flohr, C; Irvine, AD	1
Kuester, D; Limpens, J; Roekevisch, E; Schmitt, J; Spuls, PI	1
Armbrecht, ES; Flanagan, KH; Rahman, SI; Siegfried, E	1
Deo, M; Hill, S; Rademaker, M; Yung, A	1
Flohr, C; Tsakok, T	1
Irvine, AD	1
Begolka, WS; Berger, TG; Bergman, JN; Block, J; Chamlin, SL; Cohen, DE; Cooper, KD; Cordoro, KM; Davis, DM; Eichenfield, LF; Elmets, CA; Feldman, SR; Hanifin, JM; Harrod, CG; Krol, A; Margolis, DJ; Paller, AS; Schwarzenberger, K; Sidbury, R; Silverman, RA; Simpson, EL; Tom, WL; Williams, HC	1
de Bruin-Weller, MS; Deinum, J; Garritsen, FM; Roekevisch, E; Spuls, PI; van der Schaft, J	1
Coenraads, PJ; de Bruin-Weller, MS; Politiek, K; Schuttelaar, ML; van der Schaft, J	1
Scott, M	1
Luger, TA; Tsianakas, A	1
Notaro, ER; Sidbury, R	1
Aljuffali, IA; Fang, JY; Fang, YP; Kao, HC; Lee, CH; Yang, SH	1
Amazan, E; Boralevi, F; Ezzedine, K; Milpied, B; Seneschal, J; Taïeb, A; Védie, AL	1
Chan, YC; Chandran, NS; Ho, MS; Koh, MJ; Lim, YL; Tang, MB; Tay, YK; Thirumoorthy, T	1
Deleuran, MS; Hjuler, KF; Iversen, L; Jakobsen, L; Olsen, M; Riis, JL; Vestergaard, C	1
Cordoro, K; Eichenfield, LF; Flohr, C; Lara-Corrales, I; Logan, K; Paller, AS; Proudfoot, L; Schmitt, J; Siegfried, E; Sugarman, J; Tom, W; Totri, CR	1
Abraham, S; Augustin, M; Bieber, T; Elsner, P; Fölster-Holst, R; Homey, B; Kleinheinz, A; Novak, N; Schmitt, J; Stephan, V; Sticherling, M; Trautmann, F; Weidinger, S; Werfel, T	1
Bos, JD; Campbell, LE; Irwin McLean, WH; Kezic, S; Leeflang, MMG; Middelkamp-Hup, MA; Roekevisch, E; Schram, ME; Spuls, PI	1
Chong, JH; Koh, MJA	1
Bergman, R; Ramon, M; Zoller, L	1
Amichai, B; Barzilai, A; Baum, S; Heyman, R; Lyakhovitsky, A; Shpiro, D; Solomon, M; Trau, H	1
Burkhart, CN; Morrell, DS; Shaw, MG	1
Bos, JD; Leeflang, MM; Roekevisch, E; Schmitt, J; Schram, ME; Spuls, PI	1
Simon, D	1
de-la-Cuadra-Oyanguren, J; Esteve-Martínez, A; García-Rabasco, A; Miralles, J	1
Beck, LA; Denby, KS	1
Gonzalez, ME; Tan, AU	1
Eassa, B; El-Khalawany, MA; Ghonaim, N; Hassan, H; Shaaban, D	1
Laube, S; Smith, AG; Stephens, M; Tan, BB; Whittaker, SJ	1
Balasubramaniam, P; Ilchyshyn, A	1
Meggitt, SJ; Reynolds, NJ; Wahie, S; Weatherhead, SC	1
Ardern-Jones, M; Bateman, EA; Ogg, GS	1
Bridts, CH; De Clerck, LS; De Schutter, L; Schuerwegh, AJ; Stevens, WJ; Verbruggen, A	1
Morison, WL	1
Anderson, C	1
Cotton, DW; van Rossum, E	1

Reviews

19 review(s) available for methotrexate and Dermatitis, Atopic

Article	Year
Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis. The Annals of pharmacotherapy, 2023, Volume: 57, Issue:1 Topics: Adolescent; Biological Products; Cyclosporins; Dermatitis, Atopic; Double-Blind Method; Humans; Immunoglobulin A; Janus Kinases; Methotrexate; Prednisone; Severity of Illness Index; Signal Transduction; STAT Transcription Factors; Treatment Outcome	2023
Expert consensus on the systemic treatment of atopic dermatitis in special populations. Journal of the European Academy of Dermatology and Venereology : JEADV, 2023, Volume: 37, Issue:6 Topics: Aged; Asthma; Cyclosporine; Dermatitis, Atopic; Female; Humans; Methotrexate; Mycophenolic Acid	2023
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis. JAMA dermatology, 2020, 06-01, Volume: 156, Issue:6 Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunologic Factors; Methotrexate; Network Meta-Analysis; Pruritus; Quality of Life; Severity of Illness Index; Treatment Outcome	2020
Long-Term Treatment of Atopic Dermatitis. Dermatologic clinics, 2017, Volume: 35, Issue:3 Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Azathioprine; Baths; Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Phototherapy; Randomized Controlled Trials as Topic; Skin Cream; Time Factors	2017
Atopic dermatitis: phototherapy and systemic therapy. Seminars in cutaneous medicine and surgery, 2017, Volume: 36, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Interleukin-13; Interleukin-4; Methotrexate; Mycophenolic Acid; Phototherapy	2017
Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review. Pediatrics, 2018, Volume: 141, Issue:Suppl 5 Topics: Anti-Inflammatory Agents; Child; Conjunctivitis, Allergic; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisone	2018
Atopic dermatitis. Nature reviews. Disease primers, 2018, 06-21, Volume: 4, Issue:1 Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Calcineurin Inhibitors; Chronic Disease; Dermatitis, Atopic; Filaggrin Proteins; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Intermediate Filament Proteins; Methotrexate; Phosphodiesterase 4 Inhibitors; Quality of Life; Severity of Illness Index; Urticaria	2018
Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution? F1000Research, 2019, Volume: 8 Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Randomized Controlled Trials as Topic	2019
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. The Journal of allergy and clinical immunology, 2014, Volume: 133, Issue:2 Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mycophenolic Acid	2014
Question 1: Role of methotrexate in severe atopic eczema in children. Archives of disease in childhood, 2015, Volume: 100, Issue:8 Topics: Child; Dermatitis, Atopic; Dermatologic Agents; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Methotrexate	2015
Systemic Agents for Severe Atopic Dermatitis in Children. Paediatric drugs, 2015, Volume: 17, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Drug Administration Routes; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Thalidomide	2015
Guidelines for the Management of Atopic Dermatitis in Singapore. Annals of the Academy of Medicine, Singapore, 2016, Volume: 45, Issue:10 Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Calcineurin Inhibitors; Coinfection; Cyclosporine; Dermatitis, Atopic; Dermatology; Disease Management; Emollients; Food Hypersensitivity; Humans; Immunosuppressive Agents; Methotrexate; Patient Education as Topic; Phototherapy; Practice Guidelines as Topic; Referral and Consultation; Severity of Illness Index; Singapore	2016
Non-topical management of recalcitrant paediatric atopic dermatitis. Archives of disease in childhood, 2017, Volume: 102, Issue:7 Topics: Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Medicine, Chinese Traditional; Methotrexate; Mycophenolic Acid; Phototherapy; Prebiotics; Probiotics; Recurrence; Ultraviolet Therapy	2017
Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician. Pediatric annals, 2009, Volume: 38, Issue:7 Topics: Algorithms; Anti-Bacterial Agents; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Emollients; Glucocorticoids; Histamine Antagonists; Humans; Immunoglobulins; Immunologic Factors; Infant; Infusions, Intravenous; Interferon-gamma; Methotrexate; Mycophenolic Acid; Phototherapy; Primary Health Care; Severity of Illness Index; Treatment Outcome	2009
Systemic therapy of atopic dermatitis in children and adults. Current problems in dermatology, 2011, Volume: 41 Topics: Adrenal Cortex Hormones; Adult; Alitretinoin; Antibodies, Monoclonal; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mycophenolic Acid; Recombinant Proteins; Tretinoin	2011
Update on systemic therapies for atopic dermatitis. Current opinion in allergy and clinical immunology, 2012, Volume: 12, Issue:4 Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kaposi Varicelliform Eruption; Male; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Risk Factors	2012
Management of severe atopic dermatitis in children. Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:10 Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Baths; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Disinfectants; Humans; Immunosuppressive Agents; Infant; Methotrexate; Mycophenolic Acid; Sodium Hypochlorite; Ultraviolet Therapy	2012
Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy. The British journal of dermatology, 2005, Volume: 152, Issue:6 Topics: Adult; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Lymphomatoid Papulosis; Male; Methotrexate	2005
Phototherapy and photochemotherapy. Advances in dermatology, 1992, Volume: 7 Topics: Dermatitis, Atopic; Humans; Methotrexate; Mycosis Fungoides; Photochemotherapy; Phototherapy; Psoriasis; PUVA Therapy; Skin Diseases; Skin Neoplasms; Ultraviolet Therapy	1992

Trials

8 trial(s) available for methotrexate and Dermatitis, Atopic

Article	Year
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. The British journal of dermatology, 2023, 11-16, Volume: 189, Issue:6 Topics: Adolescent; Child; Cyclosporine; Dermatitis, Atopic; Double-Blind Method; Filaggrin Proteins; Humans; Methotrexate; Odds Ratio; Severity of Illness Index; Treatment Outcome	2023
Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial. The British journal of dermatology, 2018, Volume: 178, Issue:6 Topics: Adult; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Drug Administration Schedule; Drug Substitution; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Off-Label Use; Single-Blind Method; Treatment Outcome	2018
A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT). The British journal of dermatology, 2018, Volume: 179, Issue:6 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cost-Benefit Analysis; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Female; Filaggrin Proteins; Humans; Intermediate Filament Proteins; Male; Methotrexate; Multicenter Studies as Topic; Pragmatic Clinical Trials as Topic; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome	2018
Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment. The British journal of dermatology, 2017, Volume: 177, Issue:6 Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Filaggrin Proteins; Humans; Immunosuppressive Agents; Intermediate Filament Proteins; Loss of Function Mutation; Male; Methotrexate; Middle Aged; Treatment Outcome	2017
Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. The Israel Medical Association journal : IMAJ, 2008, Volume: 10, Issue:6 Topics: Age of Onset; Aged; Aged, 80 and over; Dermatitis, Atopic; Dermatologic Agents; Drug Administration Schedule; Eczema; Female; Folic Acid; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome	2008
A randomized trial of methotrexate versus azathioprine for severe atopic eczema. The Journal of allergy and clinical immunology, 2011, Volume: 128, Issue:2 Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Quality of Life; Severity of Illness Index; Treatment Outcome	2011
Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt. European journal of pediatrics, 2013, Volume: 172, Issue:3 Topics: Administration, Oral; Adolescent; Child; Cyclosporine; Dermatitis, Atopic; Drug Administration Schedule; Egypt; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Severity of Illness Index; Treatment Outcome	2013
An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. The British journal of dermatology, 2007, Volume: 156, Issue:2 Topics: Administration, Oral; Adult; Dermatitis, Atopic; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome	2007

Other Studies

55 other study(ies) available for methotrexate and Dermatitis, Atopic

Article	Year
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD). The Journal of dermatological treatment, 2022, Volume: 33, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Severity of Illness Index; Treatment Outcome	2022
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:11 Topics: Adolescent; Azathioprine; Biological Products; Child; Child, Preschool; Cyclosporine; Delphi Technique; Dermatitis, Atopic; Expert Testimony; Humans; Janus Kinase Inhibitors; Janus Kinases; Methotrexate; Mycophenolic Acid; Quality of Life	2022
Treatment Patterns among Patients with Atopic Dermatitis in Secondary Care: A National, Observational, Non-interventional, Retrospective Study in Sweden. Acta dermato-venereologica, 2022, Sep-06, Volume: 102 Topics: Dermatitis, Atopic; Humans; Longitudinal Studies; Methotrexate; Retrospective Studies; Secondary Care; Sweden	2022
Annual Trends in Medicare Part D Prescription Claims for Dupilumab 2017 to 2019. Journal of drugs in dermatology : JDD, 2022, Oct-01, Volume: 21, Issue:10 Topics: Aged; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Humans; Medicare Part D; Methotrexate; Prescriptions; Severity of Illness Index; Treatment Outcome; United States	2022
Systemic treatment for severe atopic dermatitis in children: a case series. Boletin medico del Hospital Infantil de Mexico, 2022, Volume: 79, Issue:5 Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycophenolic Acid; Prednisone; Thalidomide	2022
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis. Pharmacoepidemiology and drug safety, 2023, Volume: 32, Issue:5 Topics: Adjuvants, Immunologic; Adult; Antibodies, Monoclonal, Humanized; Dermatitis, Atopic; Humans; Immunologic Factors; Methotrexate; Severity of Illness Index; Treatment Outcome; United States	2023
Chronic actinic dermatitis successfully treated with methotrexate and dupilumab. Photodermatology, photoimmunology & photomedicine, 2023, Volume: 39, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Dermatitis, Atopic; Humans; Methotrexate; Photosensitivity Disorders; Severity of Illness Index; Treatment Outcome	2023
A clinical trial in children and young people with severe eczema comparing methotrexate with ciclosporin. The British journal of dermatology, 2023, 11-16, Volume: 189, Issue:6 Topics: Adolescent; Child; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Methotrexate	2023
Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease. Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:6 Topics: Azathioprine; Cross-Sectional Studies; Cyclosporine; Dermatitis, Atopic; Drug Eruptions; Drug Monitoring; Humans; Methotrexate; Mycophenolic Acid; Psoriasis; United States	2020
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry. Allergy, 2020, Volume: 75, Issue:9 Topics: Adult; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Pharmaceutical Preparations; Registries	2020
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy. Dermatology (Basel, Switzerland), 2021, Volume: 237, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Retrospective Studies; Ultraviolet Therapy	2021
Developmental cell programs are co-opted in inflammatory skin disease. Science (New York, N.Y.), 2021, 01-22, Volume: 371, Issue:6527 Topics: Animals; Atlases as Topic; Cell Movement; Datasets as Topic; Dendritic Cells; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunity, Innate; Methotrexate; Mice; Phagocytes; Psoriasis; Single-Cell Analysis; Skin; T-Lymphocytes; Transcriptome	2021
Methotrexate for atopic dermatitis in adults: a prospective study from a reference center in Brazil. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021, Volume: 19, Issue:2 Topics: Adult; Brazil; Dermatitis, Atopic; Eczema; Humans; Methotrexate; Prospective Studies	2021
Novel agents for atopic dermatitis in patients over 50 years of age: A case series. Dermatologic therapy, 2021, Volume: 34, Issue:2 Topics: Aged; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Infant; Methotrexate; Treatment Outcome	2021
Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients. European journal of dermatology : EJD, 2021, Apr-01, Volume: 31, Issue:2 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Outpatients; Patient Satisfaction; Probability; Proportional Hazards Models; Retrospective Studies; Young Adult	2021
A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents. Experimental dermatology, 2018, Volume: 27, Issue:1 Topics: Animals; Cyclosporine; Cytokines; Dermatitis, Atopic; Female; Haptens; Humans; Immunoglobulin E; Inflammation; Interleukin-23; Interleukin-23 Subunit p19; Janus Kinase Inhibitors; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyrroles; Rats; Rats, Inbred BN; Skin; Thymic Stromal Lymphopoietin	2018
Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center. Pediatric dermatology, 2017, Volume: 34, Issue:5 Topics: Child; Child, Preschool; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Quality of Life; Retrospective Studies; Tertiary Care Centers; Treatment Outcome	2017
Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data. The Journal of allergy and clinical immunology, 2018, Volume: 141, Issue:2 Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Filaggrin Proteins; Follow-Up Studies; Humans; Intermediate Filament Proteins; Male; Methotrexate	2018
Methotrexate does not impede the development of contact allergy. Contact dermatitis, 2018, Volume: 78, Issue:3 Topics: Acyclic Monoterpenes; Adult; Dermatitis, Allergic Contact; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Methotrexate; Monoterpenes; Nickel; Patch Tests	2018
[Current and upcoming treatments of adult atopic dermatitis]. Annales de dermatologie et de venereologie, 2017, Volume: 144 Suppl 5 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Thalidomide; Ustekinumab	2017
Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:8 Topics: Adult; Alphavirus; Cyclosporine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Proportional Hazards Models; Retrospective Studies; Time Factors; Young Adult	2018
Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:8 Topics: Administration, Oral; Azathioprine; Cyclosporine; Databases, Factual; Dermatitis, Atopic; Drug Prescriptions; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Netherlands	2018
Tolerance of methotrexate in a daily practice cohort of adults with atopic dermatitis. European journal of dermatology : EJD, 2018, 04-01, Volume: 28, Issue:2 Topics: Administration, Oral; Adult; Cohort Studies; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2018
UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country. International journal of dermatology, 2018, Volume: 57, Issue:7 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Colombia; Dermatitis, Atopic; Developing Countries; Emollients; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Recurrence; Retrospective Studies; Severity of Illness Index; Ultraviolet Therapy; Young Adult	2018
Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine. The British journal of dermatology, 2018, Volume: 178, Issue:6 Topics: Azathioprine; Dermatitis, Atopic; Follow-Up Studies; Humans; Methotrexate; Mycophenolic Acid	2018
PHARMACOGENETIC EFFECTS OF METHOTREXATE (MTX) IN UKRAINIAN PATIENTS DEPENDING ON THE MTHFR GENOTYPES (CLINICAL CASES). Georgian medical news, 2018, Issue:279 Topics: Adult; Dermatitis, Atopic; Female; Genotype; Humans; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pregnancy; Pregnancy, Ectopic; Psoriasis; Ukraine; Young Adult	2018
The use of methotrexate for treating childhood atopic dermatitis: a multicenter retrospective study. The Journal of dermatological treatment, 2019, Volume: 30, Issue:3 Topics: Adolescent; Child; Dermatitis, Atopic; Female; Humans; Male; Methotrexate; Patient Satisfaction; Retrospective Studies; Treatment Outcome	2019
Generating new evidence for old medications: the TREAT trial in paediatric atopic dermatitis. The British journal of dermatology, 2018, Volume: 179, Issue:4 Topics: Child; Cost-Benefit Analysis; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Methotrexate	2018
Methotrexate in atopic eczema. Comments to: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:4 Topics: Adult; Child; Consensus; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Methotrexate	2019
Methotrexate in atopic eczema - Reply to a letter. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:4 Topics: Adult; Child; Consensus; Dermatitis, Atopic; Eczema; Humans; Methotrexate; Treatment Outcome	2019
Kaposi varicelliform eruption induced by methotrexate in an adult atopic dermatitis patient. Dermatologic therapy, 2019, Volume: 32, Issue:2 Topics: Adult; Dermatitis, Atopic; Dermatologic Agents; Humans; Kaposi Varicelliform Eruption; Male; Methotrexate	2019
Treatment of severe pediatric atopic dermatitis with methotrexate: A retrospective review. Pediatric dermatology, 2019, Volume: 36, Issue:3 Topics: Adolescent; Child; Child, Preschool; Dermatitis, Atopic; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Retrospective Studies; Treatment Outcome; Young Adult	2019
Long-term effect of methotrexate for childhood atopic dermatitis. Journal of paediatrics and child health, 2019, Volume: 55, Issue:12 Topics: Adolescent; Child; Child, Preschool; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; New Zealand; Outcome Assessment, Health Care; Severity of Illness Index	2019
Acute arthritis and arthralgia as an adverse drug reaction to dupilumab. Clinical and experimental dermatology, 2020, Volume: 45, Issue:2 Topics: Adult; Antibodies, Monoclonal, Humanized; Arthralgia; Arthritis; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Methotrexate	2020
Systemic therapies for severe atopic dermatitis in children and adults. The Journal of allergy and clinical immunology, 2013, Volume: 132, Issue:3 Topics: Adult; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Male; Methotrexate; Quality of Life	2013
The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children. Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:2 Topics: Administration, Oral; Adolescent; Age Factors; Child; Child, Preschool; Cohort Studies; Dermatitis; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Administration Schedule; Eczema; Female; Follow-Up Studies; Humans; Male; Methotrexate; Polyglutamic Acid; Psoriasis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome	2014
Methotrexate for treatment of atopic dermatitis in children and adolescents. International journal of dermatology, 2014, Volume: 53, Issue:8 Topics: Adolescent; Child; Child, Preschool; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Nausea; Retrospective Studies	2014
Methotrexate vs. ciclosporin in the treatment of severe atopic dermatitis in children: a critical appraisal. The British journal of dermatology, 2014, Volume: 170, Issue:3 Topics: Cyclosporine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexate	2014
Commentary: Methotrexate and ciclosporin in the treatment of severe eczema in children. The British journal of dermatology, 2014, Volume: 170, Issue:3 Topics: Cyclosporine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexate	2014
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:2 Topics: Anti-Infective Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Histamine Antagonists; Humans; Immunologic Factors; Interferon-gamma; Methotrexate; Mycophenolic Acid; Phototherapy	2014
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:10 Topics: Academic Medical Centers; Administration, Oral; Adult; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Tacrolimus; Young Adult	2015
Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis. The British journal of dermatology, 2016, Volume: 174, Issue:1 Topics: Dermatitis, Atopic; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome	2016
The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis. Expert opinion on biological therapy, 2015, Volume: 15, Issue:11 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Methotrexate; Quality of Life; Receptors, Interleukin-4; Treatment Outcome	2015
What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model. International journal of pharmaceutics, 2016, Jan-30, Volume: 497, Issue:1-2 Topics: Animals; Cytokines; Dermatitis, Atopic; Dextrans; Filaggrin Proteins; Methotrexate; Methoxsalen; Mice; Models, Biological; Ovalbumin; Pharmaceutical Preparations; Skin; Skin Absorption; Tacrolimus; Water Loss, Insensible	2016
Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study. Acta dermato-venereologica, 2016, Aug-23, Volume: 96, Issue:6 Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Dermatitis, Atopic; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome	2016
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study. BMJ open, 2016, 11-11, Volume: 6, Issue:11 Topics: Adult; Aged; Ambulatory Care; Azathioprine; Case-Control Studies; Cyclosporine; Denmark; Dermatitis, Atopic; Eczema; Female; Follow-Up Studies; Hospitalization; Hospitals; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Myocardial Infarction; Registries; Risk Factors; Young Adult	2016
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:2 Topics: Adult; Azathioprine; Canada; Child; Cyclosporine; Dermatitis, Atopic; Dermatology; Drug Prescriptions; Female; Health Care Surveys; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pediatrics; Practice Patterns, Physicians'; Severity of Illness Index; United States	2017
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2017, Volume: 15, Issue:1 Topics: Adult; Alitretinoin; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; Leflunomide; Long-Term Care; Male; Methotrexate; Mycophenolic Acid; Prednisolone; Registries; Treatment Outcome	2017
Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Dermatitis, Atopic; Dose-Response Relationship, Drug; Female; Folic Acid; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Severity of Illness Index	2010
[Treatment-resistant adult atopic dermatitis]. Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatitis, Occupational; Dietary Proteins; Drug Resistance; Facial Dermatoses; Female; Food Hypersensitivity; Hand Dermatoses; Histamine Antagonists; Humans; Immunosuppressive Agents; Methotrexate; Patch Tests; Skin Tests; Tacrolimus	2011
Successful treatment of severe atopic dermatitis with methotrexate. Clinical and experimental dermatology, 2005, Volume: 30, Issue:4 Topics: Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged	2005
Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate. The British journal of dermatology, 2007, Volume: 156, Issue:6 Topics: Adult; Allergens; Dermatitis, Atopic; Dermatologic Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Female; HLA-A Antigens; HLA-DRB1 Chains; Humans; Male; Methotrexate; Recurrence; T-Lymphocytes	2007
Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis. Cytokine, 1999, Volume: 11, Issue:10 Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Asthma; CD8-Positive T-Lymphocytes; Cytokines; Dermatitis, Atopic; Flow Cytometry; Humans; Interferon-gamma; Interleukin-2; Interleukin-4; Interleukin-5; Lymphocyte Count; Methotrexate; Middle Aged; T-Lymphocytes, Helper-Inducer	1999
The effect of some immunomodulating agents on the sensitization phase of experimental contact allergic reactions. International archives of allergy and applied immunology, 1986, Volume: 79, Issue:2 Topics: Animals; Azathioprine; Cyclophosphamide; Dermatitis, Atopic; Dermatitis, Contact; Dose-Response Relationship, Drug; Female; Guinea Pigs; Immunization; Methotrexate; Time Factors	1986
Glucose-6-phosphate dehydrogenase in the blood of psoriatics, and the effects of methotrexate. Dermatologica, 1973, Volume: 147, Issue:6 Topics: Dermatitis, Atopic; Enzyme Repression; Female; Glucosephosphate Dehydrogenase; Humans; Male; Methotrexate; Mycosis Fungoides; NAD; NADP; Psoriasis; Spectrophotometry, Ultraviolet; Time Factors	1973